UREMOL HC 10 %
UREA : 10 % HYDROCORTISONE ACETATE : 1 % · DIN 00503134 · GLAXOSMITHKLINE INC
Health Canada status: CANCELLED POST MARKET
What is UREMOL HC?
UREMOL HC 10 % contains UREA : 10 % HYDROCORTISONE ACETATE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 00503134, held by GLAXOSMITHKLINE INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 23-Jun-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is UREMOL HC used for?
Topical therapy of corticosteroid responsive dermatoses with dry skin conditions where anti-inflammatory and antipruritic activity is required. Maximum duration 4 weeks.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00503134 |
|---|---|
| Brand name | UREMOL HC |
| Generic / active ingredient | UREA : 10 % HYDROCORTISONE ACETATE : 1 % |
| Manufacturer | GLAXOSMITHKLINE INC |
| Strength | 10 % |
| Dosage form | CREAM |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07XA01 HYDROCORTISONE |
| AHFS class | 84:06.00 ; 84:28.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 23-Jun-2014 |
| Original market date | 1981-12-31 00:00:00 |
How is it administered?
Apply a thin layer to affected areas once or twice a day for a maximum of 4 weeks. Affected area should be clean and dry. Avoid abrupt discontinuation.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not specified in provided text (Table of Contents lists section but text ends before it).
How is it supplied?
Not explicitly detailed in text (mentions 'container' and 'excess product should not be returned to the container').
Contraindications
Hypersensitivity to hydrocortisone, urea, or other corticosteroids; bacterial, tubercular, fungal, viral, or parasitic skin infections; rosacea; acne vulgaris; pruritus without inflammation; eye use.
Warnings and precautions
Risk of HPA axis suppression and Cushing’s syndrome; do not use under occlusion; keep away from eyes/mucous membranes; avoid use on open wounds; potential for skin atrophy with prolonged use.
What can be used instead?
Other Canadian products sharing ATC code D07XA01 HYDROCORTISONE. 2 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PRAMOX HC CREAM | 1 % | CREAM | DERMTEK PHARMA INC | MARKETED | DIN 00770957 |
| PRAMOX HC LOTION | 1 % | LOTION | DERMTEK PHARMA INC | MARKETED | DIN 01954210 |
| CALMURID HC CRM | 100 MG | CREAM | GALDERMA CANADA INC | CANCELLED POST MARKET | DIN 02010720 |
| STEREX CRM PLUS | 1 % | CREAM | INTERNATIONAL DERMATOLOGICALS INC. | CANCELLED POST MARKET | DIN 00449768 |
| STEREX LOT PLUS | 3 % | LOTION | INTERNATIONAL DERMATOLOGICALS INC. | CANCELLED POST MARKET | DIN 00456403 |
| TI-U-LAC HC LOTION | 100 MG | LOTION | MERIT INDUSTRIES INC. | CANCELLED POST MARKET | DIN 01944096 |
| UREMOL HC | 1 % | LOTION | GLAXOSMITHKLINE INC | CANCELLED POST MARKET | DIN 00560022 |
Who else supplies HYDROCORTISONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROCORTISONE appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.